MetLife, Inc. (MET) Balance Sheet

The sequential increase in total assets from $743.2B in Q1 2026 to $748.1B in Q2 2026, coupled with a stable equity base, implies that the balance sheet expansion is being financed by increased policyholder liabilities and debt. This trend may indicate ongoing premium growth and reserve accumulation, but the lack of equity growth raises questions about capital generation efficiency. Investors should monitor whether this trajectory continues and whether it translates into improved ROE, which has been volatile, ranging from 2.5% to 4.6% over the past year.

The reported investment figure is likely a data artifact, but the absence of meaningful investment income and yield data limits the ability to assess portfolio performance. Given the rising rate environment, MetLife's general account likely benefits from higher reinvestment rates, but the unrealized loss position remains undisclosed. Analysts should seek additional disclosures to evaluate the quality and duration of the fixed-income portfolio, especially in light of the company's significant exposure to commercial real estate, which may pose impairment risks.

The loss ratio has remained below 75% for most quarters, with a notable dip to 62.8% in Q1 2026, suggesting favorable reserve development or strong underwriting. However, the spike to 82.6% in Q3 2025 warrants attention, as it may indicate a one-time event or emerging pressure. The combined ratio consistently below 100% implies that reserves are sufficient to cover claims, but the long-tail nature of life insurance liabilities means inflation and interest rate changes could affect future reserve adequacy.

The equity-to-assets ratio has hovered around 3.6-4.1% over the past year, which is modest for a life insurer and may limit the capacity for additional buybacks or M&A. While MetLife's adjusted ROE of 17% year-to-date suggests strong operational performance, the thin equity base amplifies the impact of investment losses or reserve charges. The company's ability to maintain its capital return program depends on continued earnings generation and favorable market conditions.

The steady operating cash flow, driven by premium collections, provides a solid foundation for claims-paying ability. However, the balance sheet data does not disclose cash holdings or liquid asset buffers, making it difficult to assess the immediate liquidity position. The large investment purchases and sales, exceeding $30B in Q2 2026, suggest active portfolio management but also introduce potential liquidity risk if markets become stressed.